Try our Advanced Search for more refined results

Amgen Inc. v. Amneal Pharmaceuticals et al

  1. September 21, 2017

    Breckenridge Admits Sensipar Generic Violates Amgen Patent

    A Delaware federal judge on Thursday approved a settlement in which Breckenridge Pharmaceutical Inc. admitted it infringed Amgen Inc.'s patent for its calcium reducer Sensipar when it asked the U.S. Food and Drug Administration to approve generics before the patent expired. 

  2. September 26, 2016

    Amgen Sues Actavis, Indian Cos. Over Sensipar Generics

    Amgen Inc. accused Actavis Inc.'s Watson Laboratories Inc. and two Indian drug companies in Delaware federal court of infringing a patent for its blockbuster calcium reducer Sensipar when asking the U.S. Food and Drug Administration to approve generics before the patent expired.